Works by Gilham, Dean
Results: 11
Inhibitors of hepatic microsomal triacylglycerol hydrolase decrease very low density lipoprotein secretion.
- Published in:
- FASEB Journal, 2003, v. 17, n. 12, p. 1685, doi. 10.1096/fj.02-0728fje
- By:
- Publication type:
- Article
Apabetalone, a Clinical-Stage, Selective BET Inhibitor, Opposes DUX4 Target Gene Expression in Primary Human FSHD Muscle Cells.
- Published in:
- Biomedicines, 2023, v. 11, n. 10, p. 2683, doi. 10.3390/biomedicines11102683
- By:
- Publication type:
- Article
Apabetalone Downregulates Fibrotic, Inflammatory and Calcific Processes in Renal Mesangial Cells and Patients with Renal Impairment.
- Published in:
- Biomedicines, 2023, v. 11, n. 6, p. 1663, doi. 10.3390/biomedicines11061663
- By:
- Publication type:
- Article
Bromodomain and Extraterminal Protein Inhibitor, Apabetalone (RVX-208), Reduces ACE2 Expression and Attenuates SARS-Cov-2 Infection In Vitro.
- Published in:
- Biomedicines, 2021, v. 9, n. 4, p. 437, doi. 10.3390/biomedicines9040437
- By:
- Publication type:
- Article
FO080 APABETALONE, AN INHIBITOR OF BET PROTEINS, IMPROVES CARDIOVASCULAR RISK AND REDUCES ALKALINE PHOSPHATASE IN BOTH CVD PATIENTS AND PRIMARY HUMAN CELL CULTURE SYSTEMS.
- Published in:
- Nephrology Dialysis Transplantation, 2019, v. 34, p. N.PAG, doi. 10.1093/ndt/gfz096.FO080
- By:
- Publication type:
- Article
The Physiological Role of Triacylglycerol Hydrolase in Lipid Metabolism.
- Published in:
- Reviews in Endocrine & Metabolic Disorders, 2004, v. 5, n. 4, p. 303
- By:
- Publication type:
- Article
Epigenetic Modulation by Apabetalone Counters Cytokine-Driven Acute Phase Response In Vitro, in Mice and in Patients with Cardiovascular Disease.
- Published in:
- Cardiovascular Therapeutics, 2020, p. 1, doi. 10.1155/2020/9397109
- By:
- Publication type:
- Article
Adipocyte LDL receptor-related protein-1 expression modulates postprandial lipid transport and glucose homeostasis in mice.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Apabetalone (RVX-208) reduces vascular inflammation in vitro and in CVD patients by a BET-dependent epigenetic mechanism.
- Published in:
- Clinical Epigenetics, 2019, v. 11, n. 1, p. N.PAG, doi. 10.1186/s13148-019-0696-z
- By:
- Publication type:
- Article
Metabolic Control by S6 Kinases Depends on Dietary Lipids.
- Published in:
- PLoS ONE, 2012, v. 7, n. 3, p. 1, doi. 10.1371/journal.pone.0032631
- By:
- Publication type:
- Article
474-P: Apabetalone (RVX-208) Attenuates an Inflammatory Milieu that Enhances Adhesion of Monocytes to Endothelial Cells in Type 2 Diabetes Mellitus with Cardiovascular Disease Patients.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-474-P
- By:
- Publication type:
- Article